Solacyl
Active substance
ATC code
Species
Cattle (Calves) and pigs.
Indications
Calves: supportive treatment of pyrexia in acute respiratory disease in combination with appropriate (e.g. anti-infective) therapy if necessary.
Pigs: For the treatment of inflammation in combination with concurrent antibiotic therapy.
Dose to be administered and administration route
In drinking water/milk use.
Calves: 40 mg sodium salicylate per kg bodyweight once daily, for 1 to 3 consecutive days.
Administration: orally in drinking water or milk(replacer).
Pigs: 35 mg sodium salicylate per kg bodyweight per day, for 3 to 5 consecutive days.
Administration: orally in drinking water.
Based on the recommended dose and the number and weight of animals to be treated, the exact daily concentration of the veterinary medicinal product should be calculated according to the following formula:
.....mg veterinary medicinal product /kg body weight/day | x | average body weight (kg) of animals to be treated | = .... mg veterinary medicinal product per litre of drinking water / milk |
average daily water/milk consumption (l/animal) |
Alternatively the veterinary medicinal product can also be administered with the drinking water as pulse medication. Half of the calculated total daily amount of powder is mixed with 5-10 litres of clean water and stirred until evenly dispersed. This solution is then added, whilst stirring, into an amount of drinking water that will be consumed within approximately 3-4 hours and administered twice daily.
Maximum solubility of the veterinary medicinal product in water is approximately 100 g/litre.
The use of suitably calibrated weighing equipment for the administration of the calculated amount of sodium salicylate is recommended.
Adverse reactions
Cattle (Calves) and pigs:
Undetermined frequency (cannot be estimated on the available data) |
Gastrointestinal irritationa (Tarry or black stoolb), Prolonged bleedingc |
a especially in animals with pre-existing gastrointestinal disease.
b due to bleeding in the gastrointestinal tract.
c inhibition of normal blood clotting may occur incidentally. This effect is reversible and diminishes within approximately 7 days.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for contact details.
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 16849/5004 |
EAN | 8714225166015 |